Hepatitis B Delta: assessment of the knowledge and practices of hepato-gastroenterologists practicing in non-academic settings in France.

Autor: Cadranel JD; Department of Liver and Digestive Diseases, GHPSO, Creil., Zougmoré HT; Department of Liver and Digestive Diseases, GHPSO, Creil., Efole JN; Department of Liver and Digestive Diseases, GHPSO, Creil., Hanslik B; Gastroenterology Office, Montpellier., Causse X; Department of Liver and Digestive Diseases, Orléans., Rosa I; Department of Liver and Digestive Diseases, CHI Créteil., Lemaitre C; Department of Liver and Digestive Diseases, Le Havre., Mokhtari C; Department of Virology GHPSO, Creil., Baron A; Department of Liver and Digestive Diseases, Corbeil., Thevenot T; Department of Liver and Digestive Diseases, Besançon., Medmoun M; Department of Liver and Digestive Diseases, GHPSO, Creil., Smadhi R; Department of Liver and Digestive Diseases, GHPSO, Creil., Fantognon G; Department of Liver and Digestive Diseases, GHPSO, Creil., Remy AJ; Department of Liver and Digestive Diseases, Perpignan., Macaigne G; Department of Liver and Digestive Diseases, Montfermeil., Arondel Y; Department of Liver and Digestive Diseases, Haguenau., Arpurt JP; Department of Liver and Digestive Diseases, Avignon., Bellaiche G; Department of Liver and Digestive Diseases, Aulnay-sous-bois., Bourlière M; Department of Liver and Digestive Diseases, Marseille., De Kerguenec C; Department of Liver and Digestive Diseases, Saint Denis., Heluwaert F; Department of Liver and Digestive Diseases, Annecy., Verlynde J; Department of Liver and Digestive Diseases, Dunkerque., Halfon P; Department of Internal Medicine and Infectious Diseases, Alphabio Laboratory Marseille, Marseille., Roulot D; Department of Liver and Digestive Diseases, Bobigny., Carrier P; Department of Liver and Digestive Diseases, Limoges., Loustaud-Ratti V; Department of Liver and Digestive Diseases, Limoges., Lemagoarou T; Department of Medical Information, GHPSO, Creil, France.

Publikováno v: European journal of gastroenterology & hepatology [Eur J Gastroenterol Hepatol] 2024 Jun 01; Vol. 36 (6), pp. 735-741. Date of Electronic Publication: 2024 Apr 24.

14-day tailored PCR-guided triple therapy versus 14-day non-Bismuth concomitant quadruple therapy for Helicobacter pylori eradication: A multicenter, open-label randomized noninferiority controlled trial.

Autor: Amiot A; AP-HP, Hôpital Henri Mondor, Department of Gastroentérology, Universite Paris Est Creteil (UPEC), Creteil, France., Hacoon J; AP-HP, Hôpital Henri Mondor, Department of Public Health and Clinical Research Unit (URC-Mondor), Cepia, IMRB, Créteil, France., Heluwaert F; Service Hépatogastro-entérologie, Centre Hospitalier Annecy Genevois, Annecy, France., Mion F; Hospices Civils de Lyon, Department of Digestive Physiology, Université Lyon I, Inserm U1032, LabTAU, Lyon, France., Lamarque D; AP-HP, Department of Hepato-Gastroenterology, Ambroise-Pare Hospital, Paris Saclay University, University of Versailles Saint-Quentin-en-Yvelines, INSERM, Infection and Inflammation, Paris, France., Moussata D; Department of Hepato-Gastroenterology, University Hospital of Tours, Tours, France., Mimouni M; AP-HP, Paris Health Economics and Health Services Research Unit, URC Eco IdF, Hotel Dieu, 1 Place du Parvis Notre Dame, Paris, France.; Digestive Physiology, Hospices Civils de Lyon, Université de Lyon, Lyon, France., Delchier JC; AP-HP, Hôpital Henri Mondor, Department of Gastroentérology, Universite Paris Est Creteil (UPEC), Creteil, France., Durand-Zaleski I; AP-HP, Paris Health Economics and Health Services Research Unit, URC Eco IdF, Hotel Dieu, 1 Place du Parvis Notre Dame, Paris, France.; Digestive Physiology, Hospices Civils de Lyon, Université de Lyon, Lyon, France., Audureau E; AP-HP, Hôpital Henri Mondor, Department of Public Health and Clinical Research Unit (URC-Mondor), Cepia, IMRB, Créteil, France., Bastuji-Garin S; AP-HP, Hôpital Henri Mondor, Department of Public Health and Clinical Research Unit (URC-Mondor), Cepia, IMRB, Créteil, France.

Publikováno v: Helicobacter [Helicobacter] 2024 Mar-Apr; Vol. 29 (2), pp. e13076.

Antibiotic resistance prevalence and trends in patients infected with helicobacter pylori in the period 2013–2020: Results of the european registry on h. pylori management (hp-eureg)

Autor: Bujanda L., Nyssen O. P., Vaira D., Saracino I. M., Fiorini G., Lerang F., Georgopoulos S., Tepes B., Heluwaert F., Gasbarrini A., Rokkas T., Bordin D., Smith S., Lamy V., Caldas M., Resina E., Munoz R., Cosme A., Puig I., Megraud F., O'morain C., Gisbert J. P., the Hp-EuReg Investigators, Gravina A. G., Romano M.

Publikováno v: Antibiotics
Volume 10
Issue 9
Antibiotics, Vol 10, Iss 1058, p 1058 (2021)

Background: Bacterial antibiotic resistance changes over time depending on multiple factors
therefore, it is essential to monitor the susceptibility trends to reduce the resistance impact on the effectiveness of various treatments. Objective: To

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6633c5646d414390cc42aeabe23ad10
http://hdl.handle.net/11585/857742

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.